Cargando…
Lobaplatin induces apoptosis in T24 and 5637 bladder cancer cells by regulating Bcl-2 and Bax expression and inhibiting the PI3K/Akt signaling pathway
BACKGROUND: Lobaplatin (LBP) is a third-generation platinum-based drug that has been approved only in China for the treatment of several cancer types. Nonetheless, its efficacy in treating bladder cancer (BC) is unclear thus far. Through in vitro and in vivo experiments, this study aimed to explore...
Autores principales: | Yu, Qian, Lan, Tianwei, Ma, Zhina, Wang, Zhanlei, Zhang, Chunmei, Jiang, Yichuan, Zhao, Zhongyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481196/ https://www.ncbi.nlm.nih.gov/pubmed/37680227 http://dx.doi.org/10.21037/tau-23-376 |
Ejemplares similares
-
Silver Nanoparticles Exert Apoptotic Activity in Bladder Cancer 5637 Cells Through Alteration of Bax/Bcl-2 Genes Expression
por: Daei, Sajedeh, et al.
Publicado: (2022) -
Lobaplatin Inhibits Prostate Cancer Proliferation and Migration Through Regulation of BCL2 and BAX
por: Cao, Hongwen, et al.
Publicado: (2019) -
EGCG inhibited bladder cancer T24 and 5637 cell proliferation and migration via PI3K/AKT pathway
por: Luo, Ke-Wang, et al.
Publicado: (2018) -
The ERH gene regulates migration and invasion in 5637 and T24 bladder cancer cells
por: Pang, Kun, et al.
Publicado: (2019) -
Gecko proteins induce the apoptosis of bladder cancer 5637 cells by inhibiting Akt and activating the intrinsic caspase cascade
por: Kim, Geun-Young, et al.
Publicado: (2015)